Reported 8,631 shares, down 4,910 (36.3%) from the prior quarter.
Reported value -58.7%; share count -36.3% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 298000 |
| 2021-12-31 | 123000 |
| 2022-03-31 | 0 |
| 2022-06-30 | 213000 |
| 2022-09-30 | 67000 |
| 2022-12-31 | 125000 |
| 2023-03-31 | 0 |
| 2025-03-31 | 50000 |
| 2025-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2025 | Reduced | 0 | -23,446 (-100.0%) | 0 | $0 | 2025-08-08 | |
| Q1 2025 | New | 23,446 | +23,446 (0.0%) | < 0.01% | $50,000 | 2025-04-15 | |
| Q1 2023 | Reduced | 0 | -10,370 (-100.0%) | 0 | $0 | 2023-04-28 | |
| Q4 2022 | Unchanged | 10,370 | 0 (0.0%) | < 0.01% | $125,000 | 2023-02-02 | |
| Q3 2022 | Reduced | 10,370 | -36,162 (-77.7%) | < 0.01% | $67,000 | 2022-10-31 | |
| Q2 2022 | New | 46,532 | +46,532 (0.0%) | < 0.01% | $213,000 | 2022-07-29 | |
| Q1 2022 | Reduced | 0 | -8,631 (-100.0%) | 0 | $0 | 2022-04-29 | |
| Q4 2021 | Reduced | 8,631 | -4,910 (-36.3%) | < 0.01% | $123,000 | 2022-02-07 | |
| Q3 2021 | New | 13,541 | +13,541 (0.0%) | < 0.01% | $298,000 | 2021-11-01 |
Who else reported the position
124 managers reported ORAMED PHARM INC for Q4 2021.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 1,558,607 | +125,059 | < 0.01% | $22,257,000 | 15 qtrs |
| MILLENNIUM MANAGEMENT LLC | Added | 761,570 | +692,384 | < 0.01% | $10,875,000 | 10 qtrs |
| CITADEL ADVISORS LLC | Added | 534,225 | +515,329 | < 0.01% | $7,629,000 | 6 qtrs |
| STATE STREET CORPORATION | Added | 512,246 | +24,247 | < 0.01% | $7,315,000 | 3 qtrs |
| TWO SIGMA INVESTMENTS LP | New | 402,097 | +402,097 | 0.01% | $5,742,000 | 1 qtr |
| MORGAN STANLEY | Added | 386,437 | +266,432 | < 0.01% | $5,518,000 | 33 qtrs |
| VANGUARD GROUP INC | Added | 285,162 | +125,467 | < 0.01% | $4,072,000 | 3 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 245,345 | -1,626 | < 0.01% | $3,503,000 | 11 qtrs |
| NORTHERN TRUST CORPORATION | Added | 243,125 | +17,294 | < 0.01% | $3,472,000 | 3 qtrs |
| TWO SIGMA ADVISERS LP | New | 227,300 | +227,300 | < 0.01% | $3,246,000 | 1 qtr |
Filing details and methodology As reported
- Report period
- December 31, 2021
- Filed
- February 07, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 8,631
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.